Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Beta blockers have long been used in patients who have experienced a myocardial infarction. However, many new therapies are available for this patient group, and as a result, the current role of β blockers may have become uncertain. In this article we address a series of questions related to the important and continuing role of β blockade after myocardial infarction. Copyright 2002, Elsevier Science (USA). All rights reserved.

Original publication




Journal article


Progress in Cardiovascular Diseases

Publication Date





243 - 250